EUVIMEDEUVIMED entdecken
Kohortenstudie

Long-term outcomes of upfront robotic rectal cancer surgery: a single-center, retrospective cohort study in Japan

Shunsuke Kasai, Hiroyasu Kagawa, Akio Shiomi, Hitoshi Hino, Shoichi Manabe, Yusuke Yamaoka, Kai Chen, Kenji Nanishi, Chikara Maeda, Yusuke Kinugasa

Surgery Today · 2023-09 · 53 (9) · 1028-1037

DOI: 10.1007/s00595-023-02648-2 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Surgery Today, online erschienen am 08.02.2023. Verfasst von Shunsuke Kasai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Colon and Rectal Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan. Hauptthemen laut MEDLINE: Robotic Surgical Procedures, Rectal Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The purpose of this study was to evaluate the long-term outcomes of robotic rectal cancer surgery and to examine the risk factors for recurrence. METHODS: In a high-volume center in Japan, we retrospectively enrolled patients with pStage I-III rectal cancer within 15 cm of the anal verge who underwent robotic surgery from 2011 to 2017. Almost all patients underwent upfront surgery, and lateral lymph-node dissection (LLND) was performed for patients with locally advanced lower rectal cancer. We evaluated the 5-year overall survival (OS), relapse-free survival (RFS), and cumulative local recurrence (LR) rates and examined the risk factors for the RFS. RESULTS: We evaluated 488 patients who underwent robotic rectal cancer surgery, including 5.1% who underwent preoperative chemoradiotherapy to obtain clear resection margins and 33.6% who underwent LLND. There were 203, 87, and 198 patients with pStage I, II, and III, respectively, and the positive resection margin rate was 1.0%. The 5-year OS, RFS, and LR rates were 95.5%, 81.7%, and 2.2%, respectively. The independent risk factors for the RFS were the presence of venous invasion, extramural tumor deposits without lymph-node structure, and pT ≥ 3. CONCLUSION: This study demonstrated the favorable long-term outcomes of robotic rectal cancer surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Robotic Surgical ProceduresRectal NeoplasmsHumansTreatment OutcomeRetrospective StudiesJapanNeoplasm Recurrence, LocalLymph Node ExcisionNeoplasm Staging

Stichwörter der Autor:innen

Lateral lymph-node dissectionRectal cancerRobotic surgeryTumor depositsVenous invasion

Autor:innen und Institutionen

  • Division of Colon and Rectal Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Department of Gastrointestinal Surgery, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan.
  • Division of Colon and Rectal Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan. h.kagawa@scchr.jp.

Zitieren

APA

Kasai, S., Kagawa, H., Shiomi, A., Hino, H., Manabe, S., Yamaoka, Y., Chen, K., Nanishi, K., Maeda, C., & Kinugasa, Y. (2023). Long-term outcomes of upfront robotic rectal cancer surgery: a single-center, retrospective cohort study in Japan. Surgery Today, 53(9), 1028-1037. https://doi.org/10.1007/s00595-023-02648-2

Vancouver

Kasai S, Kagawa H, Shiomi A, Hino H, Manabe S, Yamaoka Y, et al. Long-term outcomes of upfront robotic rectal cancer surgery: a single-center, retrospective cohort study in Japan. Surgery Today. 2023;53(9):1028-1037. doi:10.1007/s00595-023-02648-2

BibTeX
@article{Kasai2023,
  author = {Kasai, Shunsuke and Kagawa, Hiroyasu and Shiomi, Akio and Hino, Hitoshi and Manabe, Shoichi and Yamaoka, Yusuke and Chen, Kai and Nanishi, Kenji and Maeda, Chikara and Kinugasa, Yusuke},
  title = {Long-term outcomes of upfront robotic rectal cancer surgery: a single-center, retrospective cohort study in Japan},
  journal = {Surgery Today},
  year = {2023},
  volume = {53},
  number = {9},
  pages = {1028--1037},
  doi = {10.1007/s00595-023-02648-2}
}
Kostenlos starten →